Amarin Expands Cardiovascular Risk Reduction Patent Infringement Lawsuit to Include Health Care ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 4 - First Occurrence News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from First Occurrence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In First Occurrence Today - Breaking & Trending Today
Icosapent Ethyl Included in the Chinese Society of Cardiology (CSC) Updated Guidelines for Primary Prevention of Cardiovascular Diseases
News Category Global Banking & Finance Reviews Icosapent Ethyl Included in the Chinese Society of Cardiology (CSC) Updated Guidelines for Primary Prevention of Cardiovascular Diseases Icosapent Ethyl Included in the Chinese Society of Cardiology (CSC) Updated Guidelines for Primary Prevention of Cardiovascular Diseases DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 21, 2021 — Amarin Corporation plc (NASDAQ:AMRN) today announced that the Chinese Society of Cardiology (CSC) has included icosapent ethyl in its updated Guidelines for Primary Prevention of Cardiovascular Diseases for 2021 as publis...
Source: globalbankingandfinance.com
Icosapent Ethyl Included in the Chinese Society of Cardiology (CSC) Updated Guidelines for ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Amarin Provides Preliminary 2020 Results and 2021 Outlook
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Amarin Provides Preliminary 2020 Results and 2021 Outlook Amarin Corporation plcJanuary 7, 2021 GMT Unaudited 2020 Total Net Revenue Estimated to Be Approximately $610 Million, an Increase of Approximately 42% Compared with 2019 Completion of European Regulatory Review and Submission of China Regulatory Application for VASCEPA® (icosapent ethyl) Expected in Late January or February 2021 DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) tod...
Source: apnews.com
Amarin Highlights Multiple VASCEPA® (Icosapent Ethyl)-Related Scientific Findings Presented at National Lipid Association (NLA) Scientific Sessions 2020, Including First COVID-19 Clinical Results
Amarin Highlights Multiple VASCEPA® (Icosapent Ethyl)-Related Scientific Findings Presented at National Lipid Association (NLA) Scientific Sessions 2020, Including First COVID-19 Clinical Results December 14, 2020 05:00 ET | Source: Amarin Corporation plc Amarin Corporation plc Bedminster, New Jersey, UNITED STATES REDUCE-IT® EPA Encore Presentation reinforces Eicosapentaenoic Acid (EPA) levels from VASCEPA® (icosapent ethyl) strongly correlated to cardiovascular outcomes, more so than other biomarkers VASCEPA COVID-19 CardioLink-9 Randomized Tri...
Source: globenewswire.com